Elevated serum uric acid (SUA) levels (i.e. hyperuricemia) have been associated with metabolic syndrome (MetS) and cardiovascular disease (CVD) morbidity and mortality. Elevated SUA levels predict the onset of type 2 diabetes (T2DM). SUA levels are increased during the early stages of impaired glucose metabolism. Furthermore, in diabetic patients, hyperuricemia has been linked to both micro-and macrovascular complications.
This course discussed the current updated knowledge about this important aspect of patient management.
This course is developed by an educational grant of
Credit: 1.0 CME